Arkolith/Insider Trading/PTGX/Form 4

Ali Asif

Chief Financial OfficerProtagonist Therapeutics, Inc (PTGX) · full profile →Form 4 · filed Mar 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.6M
Net Open-Market Flow
-$2.6M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 26, 2026Sell(S)25K$104.24$2.6M61K
Mar 26, 2026Option exercise(M)5K$12.17$64K86K
Mar 26, 2026Option exercise(M)20K$19.19$374K80K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 26, 2026Option exercise(M)5K—$013K
Mar 26, 2026Option exercise(M)20K—$031K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-036317) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML